Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Aurobindo Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
524804
INE406A01037
335.4746309
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
AUROPHARMA
33.48
69278.45
EPS(TTM)
Face Value(
)
Div & Yield %:
35.31
1
0.38
Back
Sword Edge Commercials Ltd
Sword-Edge Commercials Ltd - Board Meeting Outcome for Approval Of Un-Audited Financials For Quarter Ended 31St December 2023
Nov 29,2024
Outcome for the Board Meeting held on 13th February 2024 to approval of un-audited financials for quarter ended 31st December 2023